Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Gelijkaardige items

• Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
  door: Zingone, Fabiana, et al.
  Gepubliceerd in: (2020)
• Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
  door: Prentice, Ralley E., et al.
  Gepubliceerd in: (2020)
• Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
  door: Zingone, Fabiana, et al.
  Gepubliceerd in: (2020)
• Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak
  door: Zingone, Fabiana, et al.
  Gepubliceerd in: (2020)
• The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
  door: Barberio, Brigida, et al.
  Gepubliceerd in: (2021)